Severity
Critical
FDA Food recall · Reported May 9, 2018
Mitragyna Speciosa Leaf Powder Red Vein Sumatra and Mitragyna Speciosa Leaf Powder Red Vein Bali Kratom products are being recalled because they have the potential to be contamin…
Viable Solutions, LLC recalled Mitragyna Speciosa Leaf Powder Red Vein Sumatra and Mitragyna Speciosa Leaf Powder Red Ve… - a critical-severity action.
Mitragyna Speciosa Leaf Powder Red Vein Sumatra and Mitragyna Speciosa Leaf Powder Red Ve… was recalled by Viable Solutions, LLC in May 9, 2018. Reason: Mitragyna Speciosa Leaf Powder Red Vein Sumatra and Mitragyna Speciosa Leaf Powder Red Vein Bali Kratom prod…. Check the official notice for the remedy. Verify recall #F-1476-2018 with the FDA Food before acting.
The recall
Viable Solutions, LLC issued this critical-severity FDA Food recall-Mitragyna Speciosa Leaf Powder Red Vein Sumatra and Mitragyna Speciosa Leaf Powder Red Vein Bali Kratom prod….
Sourced from official FDA Food enforcement records. Verify recall #F-1476-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Food action (record #F-1476-2018) was formally reported on May 9, 2018, with the manufacturer initiating the action on April 18, 2018. It is classified under Critical severity (Class I), with a current status of Terminated. Viable Solutions, LLC is listed as the recalling firm, operating out of Nampa, ID. Federal records list the affected scope as 350 packages of Red Vein Sumatra and 350 packages of Red Vein Bali.
The documented reason for this recall is: Mitragyna Speciosa Leaf Powder Red Vein Sumatra and Mitragyna Speciosa Leaf Powder Red Vein Bali Kratom products are being recalled because they have the potential to be contaminated with Salmonella Distribution data in the federal record shows the product reached: Nationwide through internet sales. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Food - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 2,012 dietary supplements recalls on record
Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
350 packages of Red Vein Sumatra and 350 packages of Red Vein Bali
Related Recalls
6
6 from same agency
Mitragyna Speciosa Leaf Powder Red Vein Sumatra and Mitragyna Speciosa Leaf Powder Red Vein Bali, sold under the brand name Herbal-Salvation.com. The powder is packaged in kraft paper, foil-lined heat sealed pouches and sold in 25g, 100g, 250g, and 1000g. The product label is read in parts: "***herbal-salvation***Mitragyna Speciosa Leaf Powder Red Vein Sumatra***Origin: Indonesia***Disclaimer: This product is sold as a bulk botanical without directions or claims. Keep away from children***2204 Cortland Place, Nampa, ID 83678***WWW.HERBAL-SALVATION.COM***". The product label is read in parts: "***herbal-salvation***Mitragyna Speciosa Leaf Powder Red Vein Bali***Origin: Indonesia***Disclaimer: This product is sold as a bulk botanical without directions or claims. Keep away from children***2204 Cortland Place, Nampa, ID 83678***WWW.HERBAL-SALVATION.COM***".
Mitragyna Speciosa Leaf Powder Red Vein Sumatra and Mitragyna Speciosa Leaf Powder Red Vein Bali Kratom products are being recalled because they have the potential to be contaminated with Salmonella
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | F-1476-2018 |
| Date reported | May 9, 2018 |
| Date initiated | April 18, 2018 |
| Recalling firm | Viable Solutions, LLC |
| Firm location | Nampa, ID |
| Affected scope | 350 packages of Red Vein Sumatra and 350 packages of Red Vein Bali |
| Distribution | Nationwide through internet sales |
Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Two federal-filing-derived peer sets for this notice, both outside the same recalling firm and filing state so the neighborhoods are not firm or geographic containment.
Same archive severity grade (Critical), closest by report date among other firms and states.
Same product category, closest by report date among other firms and states (deduped against the severity set).
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Showing 5 of 2015 other recalls in this category.
Modern Warrior Life, LLC · 2026-07-29
Nutricia North America · 2026-07-22
Nutricia North America · 2026-07-22
MARS SNACKING · 2026-07-08
Provision Health Corp. dba PH Labs · 2026-07-08
Compare this recall with Modern Warrior Ready, Dietary Supplement, 60 CAPSULES →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Food, reported May 9, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.